IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

TODOERTI, KATIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 20.908
NA - Nord America 10.899
AS - Asia 8.609
SA - Sud America 810
AF - Africa 218
OC - Oceania 59
Continente sconosciuto - Info sul continente non disponibili 7
Totale 41.510
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.628
DE - Germania 10.443
GB - Regno Unito 4.227
CN - Cina 3.944
IT - Italia 1.878
SG - Singapore 1.744
SE - Svezia 1.094
RU - Federazione Russa 897
HK - Hong Kong 739
IN - India 602
BR - Brasile 582
FR - Francia 461
UA - Ucraina 415
NL - Olanda 382
TR - Turchia 362
IE - Irlanda 358
KR - Corea 333
FI - Finlandia 240
VN - Vietnam 232
EU - Europa 226
CA - Canada 216
ID - Indonesia 180
JP - Giappone 168
CO - Colombia 127
DK - Danimarca 111
PL - Polonia 97
EG - Egitto 82
CI - Costa d'Avorio 65
AU - Australia 53
GR - Grecia 48
AT - Austria 38
BE - Belgio 37
AR - Argentina 36
MY - Malesia 35
BD - Bangladesh 30
IQ - Iraq 28
CH - Svizzera 27
MX - Messico 27
ES - Italia 26
RO - Romania 24
TW - Taiwan 24
IR - Iran 20
ZA - Sudafrica 20
EC - Ecuador 19
UZ - Uzbekistan 19
PH - Filippine 18
CZ - Repubblica Ceca 17
NO - Norvegia 15
AE - Emirati Arabi Uniti 14
SA - Arabia Saudita 13
TH - Thailandia 13
VE - Venezuela 13
PK - Pakistan 12
AL - Albania 11
MA - Marocco 11
PY - Paraguay 11
BG - Bulgaria 9
CL - Cile 9
HU - Ungheria 9
NP - Nepal 9
TN - Tunisia 9
IL - Israele 8
JO - Giordania 8
PT - Portogallo 7
JM - Giamaica 6
KE - Kenya 6
MO - Macao, regione amministrativa speciale della Cina 6
RS - Serbia 6
UY - Uruguay 6
NZ - Nuova Zelanda 5
SC - Seychelles 5
TT - Trinidad e Tobago 5
AM - Armenia 4
AZ - Azerbaigian 4
BO - Bolivia 4
CY - Cipro 4
GE - Georgia 4
HR - Croazia 4
LU - Lussemburgo 4
MD - Moldavia 4
DO - Repubblica Dominicana 3
DZ - Algeria 3
KG - Kirghizistan 3
KW - Kuwait 3
KZ - Kazakistan 3
LI - Liechtenstein 3
LK - Sri Lanka 3
MN - Mongolia 3
PE - Perù 3
PS - Palestinian Territory 3
TJ - Tagikistan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BA - Bosnia-Erzegovina 2
BY - Bielorussia 2
BZ - Belize 2
EE - Estonia 2
ET - Etiopia 2
GA - Gabon 2
HN - Honduras 2
KH - Cambogia 2
Totale 41.688
Salva come PNG Salva come JPEG
Città #
Frankfurt am Main 7.799
Southend 3.788
Singapore 974
Ashburn 943
Beijing 940
Chandler 787
Hanover 731
Hong Kong 692
Milan 667
Boise 651
Seattle 633
Wilmington 467
Fairfield 460
Princeton 460
Dallas 363
Dublin 353
Jacksonville 329
Dearborn 326
Council Bluffs 306
Woodbridge 288
Houston 278
Nanjing 258
Ann Arbor 222
Bengaluru 221
Los Angeles 202
Mountain View 197
Cambridge 193
Shanghai 188
Redmond 184
Guangzhou 165
Somerville 161
Hefei 142
Des Moines 137
Toronto 137
Andover 135
Serra 131
Jakarta 128
Sakarya 121
Buffalo 120
Bogotá 118
Jinan 110
Boardman 109
Santa Clara 105
Berlin 100
Moscow 99
Shenyang 93
Nanchang 89
Tokyo 82
Phoenix 78
Changsha 77
Columbus 77
Tianjin 73
Warsaw 70
Redwood City 69
Abidjan 65
Cangzhou 64
New York 63
The Dalles 61
Hangzhou 60
Hebei 60
Zhengzhou 57
Helsinki 56
Wuhan 56
Eitensheim 55
Saint Petersburg 54
Ho Chi Minh City 52
Matera 51
San Diego 50
São Paulo 48
Munich 47
Athens 44
Seoul 44
Hanoi 43
London 43
Chengdu 42
Brescia 41
Fuzhou 38
Hamburg 38
Bitonto 37
Grafing 36
Roxbury 36
Dong Ket 35
Odernheim 35
Orofino 35
Pisa 35
Nuremberg 34
Kiez 33
Rome 33
Chicago 32
Kunming 32
Payette 32
San Francisco 32
Silver Spring 32
Brussels 31
Cottonwood 31
Garden Valley 31
Falls Church 30
Jiaxing 30
Turin 30
Jerome 29
Totale 28.579
Salva come PNG Salva come JPEG
Nome #
The proapoptotic effect of zoledronic acid is independent of either the bone microenvironment or the intrinsic resistance to bortezomib of myeloma cells and is enhanced by the combination with arsenic trioxide 999
IDH2 inhibition enhances proteasome inhibitor responsiveness in hematological malignancies 701
Pathogenicity of in-vivo generated intestinal Th17 lymphocytes is IFNγ dependent 480
Clinical-biological characterization of variant B chronic lymphocytic leukemia, characterized by a mantle cell lymphoma-like immunophenotype, t(11;14)(q13;q32) negative 476
COPZ1 depletion in thyroid tumor cells triggers type I IFN response and immunogenic cell death 456
Depletion of SIRT6 enzymatic activity increases acute myeloid leukemia cells vulnerability to DNA-damaging agents 441
Canonical and non canonical Hedgehog pathway in the pathogenesis of multiple myeloma 423
Halting the FGF/FGFR axis leads to anti-tumor activity in Waldenström's Macroglobulinemia by silencing MYD88 417
HOXB7 expression by myeloma cells regulates their pro-angiogenic properties in multiple myeloma patients 388
Exploiting MYC-induced PARPness to target genomic instability in multiple myeloma 378
Identification of specific transcriptional patterns associated with hyperdiploidy in multiple myeloma 365
A GBM-like V-ATPase signature directs cell-cell tumor signaling and reprogramming via large oncosomes 349
Amino acid depletion triggered by L-asparaginase sensitizes MM cells to carfilzomib by inducing mitochondria ROS-mediated cell death 349
Distinct lncRNA transcriptional fingerprints characterize progressive stages of multiple myeloma 331
A compendium of long non-coding RNAs transcriptional fingerprint in multiple myeloma 326
Whole-exome sequencing of primary plasma cell leukemia discloses heterogeneous mutational patterns 314
A distinctive trascriptional profile characterizes the chromosome 17p loss in B-cell chronic lymphocytic leukemia 302
Notch signaling drives multiple myeloma induced osteoclastogenesis 300
The ribonuclease DIS3 promotes let-7 miRNA maturation by degrading the pluripotency factor LIN28B mRNA 295
Long non-coding RNA NEAT1 targeting impairs the DNA repair machinery and triggers anti-tumor activity in multiple myeloma 295
Multiple myeloma-derived Jagged ligands increases autocrine and paracrine interleukin-6 expression in bone marrow niche 286
Expanding the repertoire of miRNAs and miRNA-offset RNAs expressed in multiple myeloma by small RNA deep sequencing 284
A compendium of DIS3 mutations and associated transcriptional signatures in plasma cell dyscrasias 274
Analysis of CD44 expression in monoclonal gammopathies : correlation between gene expression level and flow cytometry findings 273
Disentangling the microRNA regulatory milieu in multiple myeloma : integrative genomics analysis outlines mixed miRNA-TF circuits and pathway-derived networks modulated in t(4;14) patients 272
Long non-coding RNA NEAT1 shows high expression unrelated to molecular features and clinical outcome in multiple myeloma 267
The expression pattern of small nucleolar and small cajal body-specific RNAS characterizes distinct molecular subtypes of multiple myeloma 265
Analisi del numero di copie e sequenza del DNA in campioni sequenziali di melanoma alla diagnosi e recidiva=DNA copy number and whole-exome sequencing analyses in sequential myeloma samples at diagnosis and relapse 262
DIS3 mutations in multiple myeloma impact the transcriptional signature and clinical outcome 259
Identification of specific transcriptional patterns associated with hyperdiploidy in multiple myeloma 258
Genome-wide approach identify recurrent 8p21.2 loss in more aggressive form of primary plasma-cell leukemia 257
Functional impact of genomic complexity on the transcriptome of Multiple Myeloma 257
Molecular events underlying interleukin-6 independence in a subclone of the CMA-03 multiple myeloma cell line 254
Bone microenvironment cells reveal a different gene expression profiling in multiple myeloma patients as compared to healthy subjects : potential relationship with the bone status 250
miR-451a is underexpressed and targets AKT/mTOR pathway in papillary thyroid carcinoma 249
Molecular spectrum of BRAF, NRAS and KRAS gene mutations in plasma cell dyscrasias : implication for MEK-ERK pathway activation 248
IL21R expressing CD14+CD16+ monocytes expand in multiple myeloma patients leading to increased osteoclasts 247
Impact of Host Genes and Strand Selection on miRNA and miRNA* Expression 245
A novel fish-based normalization procedure for whole genome microarrays detecting accurate local copy numbers : application to multiple myeloma 244
Biological and clinical relevance of miRNA expression signatures in primary plasma cell leukemia 239
DIS3 depletion in multiple myeloma causes extensive perturbation in cell cycle progression and centrosome amplification 239
Notch targeting prevents multiple myeloma associated osteoclastogenesis 238
A SNP microarray and FISH-based procedure to detect allelic imbalances in multiple myeloma : an integrated genomics approach reveals a wide gene dosage effect 237
Integrative genomic analysis of trisomy 12 abnormality in B-cell chronic lymphocytic leukemia 237
Molecular spectrum of TP53 mutations in plasma cell dyscrasias by next generation sequencing: an Italian cohort study and overview of the literature 237
Bone microenvironment cells reveals a different gene expression profyling in multiple myeloma patients in relation to the bone status 234
Activation of long non-coding RNA NEAT1 leads to survival advantage of multiple myeloma cells by supporting a positive regulatory loop with DNA repair proteins 233
Genome-wide analysis of primary plasma cell leukemia identifies recurrent imbalances associated with changes in transcriptional profiles 232
Establishment of an interlukin-6 independent variant (CMA-03/06) of the human myeloma cell line CMA-03 : biological molecular characterization by a genomic integrative analisys 231
In silico characterization of miRNA and long non-coding RNA interplay in multiple myeloma 231
Cancer Associated Fibroblasts and Senescent Thyroid Cells in the Invasive Front of Thyroid Carcinoma 230
Molecular definition of 17P11-P12 amplification in multiple myeloma 229
Establishment of an interlukin-6 independent variant (CMA-03/06) of the human myeloma cell line CMA-03 : biological and molecular characterization by a genomic integrative analisys 228
The Notch pathway controls multiple myeloma crosstalk with the osteoclastogenic niche 227
Molecular classification and pharmacogenetics of primary plasma cell leukemia: an initial approach toward precision medicine 225
Identification of thyroid tumor cell vulnerabilities through a siRNA-based functional screening 223
Biological and molecular characterization by integrative genomics approach of CMA-03/06, a newly established interleukin-6 independent variant of the CMA-03 human myeloma cell line 222
Molecular and transcriptional characterization of 17P loss in B-cell chronic lymphocytic leukemia 222
A retained transcriptomic profile characterizes CD138+ cells in the short time progression from smoldering to active multiple myeloma 220
Bone marrow-mediated drug resistance is promoted by Jagged-induced Notch signaling in multiple myeloma 219
Gene expression profiling of multiple myeloma : implications for a molecular classification of the disease 218
Bone marrow-mediated drug resistance is promoted by Jagged-induced notch pathway in multiple myeloma 218
The role of notch pathway in multiple myeloma progression toward IL-6 independence 218
Establishment of an interlukin-6 independent variant (CMA-03/06) of the human myeloma cell line CMA-03 : biological and molecular characterization by a genomic integrative analisys 217
Integrative genomic analysis of primary plasma cell leukemia revealed strong gene and microrna dosage effect 217
The investigation of genomic profiles in primary plasma cell leukemias by means of an integrative microarray approach 215
The investigation of genomic profiles in primary plasma cell leukemias by means of an integrative microarray approach 215
Bone microenvironment cells show a different pattern of gene expression profiling in relationship with the presence of osteolytic bone lesions in multiple myeloma patients 214
Multiple myeloma-associated drug resistance : targeting the Notch pathway 214
Dioxin exposure of human CD34(+) hemopoietic cells induces gene expression modulation that recapitulates its in vivo clinical and biological effects 213
A novel fish-based normalization procedure for whole genome microarrays detection accurate local copy numbers : application to multiple myeloma 210
Jagged-induced notch signaling promotes endogenous and bone marrow-mediated drug resistance in multiple myeloma 210
Integrative genomic approach identifies deregulated micrornas in human myeloma cell lines 209
The immunomodulatory drugs lenalidomide and pomalidomide inhibit multiple myeloma-induced osteoclast formation and rankl/opg ratio in myeloma microenvironment targeting the expression of adhesion molecules 209
LncRNA NEAT1 in Paraspeckles: A Structural Scaffold for Cellular DNA Damage Response Systems? 209
Biological and Clinical Relevance of Surrogate Markers of IgVH Mutational Status in B-Cell Chronic Lymphocytic Leukemia 205
ESTABLISHMENT OF AN INTERLEUKIN-6 INDEPENDENT VARIANT (CMA-03/06) OF THE HUMAN MYELOMA CELL LINE CMA-03 : BIOLOGICAL AND MOLECULAR CHARACTERIZATION BY A GENOMIC INTEGRATIVE ANALYSIS 205
The investigation of genomic profiles in plasma cell leukemias by means of an integrative microarray approach 205
Apoptosis reprogramming triggered by splicing inhibitors sensitizes multiple myeloma cells to Venetoclax treatment 205
Transcriptional features of 1Q in multiple myeloma 204
Global microrna expression profiling in multiple myeloma identifies deregulated patterns associated with distinct molecular groups 204
A patient-adapted pilot study of lenalidomide in combination with low dose dexamethasone (LD) as initial therapy for a primary plasma cell leukemia (PPCL) 204
Molecular and biological characterization of three novel interleukin-6-dependent human myeloma cell lines 203
Genome-wide DNA copy number analysis by SNP arrays of B-cell chronic lymphocytic leukemia reveals the presence of novel molecular lesions 201
Global SNP-based mapping of B-cell chronic lymphocytic leukemia reveals the role of 2p gain in predicting clinical outcome 199
Transcriptional characterization of a prospective series of primary plasma cell leukemia revealed signatures associated with tumor progression and poorer outcome 198
Molecular and transcriptional characterization of 17p loss in B-cell chronic lymphocytic leukemia 197
Are the myeloma bone microevironment cells tumoral or not? 197
Reconstruction of transcriptional regulatory networks in multiple myeloma 197
Expression levels of NONO, a nuclear protein primarily involved in paraspeckles function, are associated with several deregulated molecular pathways and poor clinical outcome in multiple myeloma 197
Molecular targeting of the PKC-beta inhibitor enzastaurin (LY317615) in multiple myeloma 193
Epigenetic Regulation of Mitochondrial Quality Control Genes in Multiple Myeloma: A Sequenom MassARRAY Pilot Investigation on HMCLs 193
Genome-wide analysis of DNA copy number in multiple myeloma using high-density SNP arrays reveals clustering patterns with distinct transcriptional profiles 192
Integrative Genomic Approach Identifies Deregulated MicroRNAs in Human Myeloma Cell Lines 192
Integrative genomics analyses reveal molecularly distinct subgroups of B-cell chronic lymphocytic leukemia patients with 13q14 deletion 192
Notch signaling and multiple myeloma: challenging endogenous and bone marrow-mediated drug resistance 192
Integrative high-resolution microarrays approach in B-cell chronic lymphocytic leukemia reveals the presence of molecularly distinct subgroups in patients with 13Q deletion 190
Deregulated microrna expression patterns are associated with high-rish genetic groups in multiple myeloma 190
Lenalidomide plus low dose dexamethasone as first line therapy in patients with primary plasma cell leukemia : planned interim analysis of a pilot study from the gimema-italian myeloma network 190
Gene and mirna expression profiles in plasma cell leukemias 190
Totale 26.310
Salva come PNG Salva come JPEG
Categoria #
all - tutte 101.962
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 101.962
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.589 0 0 0 0 259 185 151 171 481 197 802 343
2021/20223.690 299 128 188 264 372 295 372 262 459 301 212 538
2022/20233.207 454 293 273 298 377 604 89 192 317 72 164 74
2023/20247.225 80 161 112 177 614 300 1.099 999 493 972 1.059 1.159
2024/20257.242 1.019 977 852 816 323 222 197 526 306 462 418 1.124
2025/20263.744 971 680 927 849 317 0 0 0 0 0 0 0
Totale 43.120